Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Surgery Partners (SGRY) over the last 12 years, with Q3 2025 value amounting to $6.8 billion.

  • Surgery Partners' Non-Current Assets rose 532.11% to $6.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $27.3 billion, marking a year-over-year increase of 919.87%. This contributed to the annual value of $6.8 billion for FY2024, which is 1318.86% up from last year.
  • As of Q3 2025, Surgery Partners' Non-Current Assets stood at $6.8 billion, which was up 532.11% from $6.8 billion recorded in Q2 2025.
  • Surgery Partners' 5-year Non-Current Assets high stood at $6.9 billion for Q1 2025, and its period low was $4.6 billion during Q1 2021.
  • For the 5-year period, Surgery Partners' Non-Current Assets averaged around $5.9 billion, with its median value being $5.8 billion (2023).
  • Its Non-Current Assets has fluctuated over the past 5 years, first surged by 2105.05% in 2022, then skyrocketed by 182.3% in 2023.
  • Surgery Partners' Non-Current Assets (Quarter) stood at $5.2 billion in 2021, then grew by 11.4% to $5.8 billion in 2022, then grew by 3.83% to $6.0 billion in 2023, then increased by 13.19% to $6.8 billion in 2024, then increased by 1.09% to $6.8 billion in 2025.
  • Its last three reported values are $6.8 billion in Q3 2025, $6.8 billion for Q2 2025, and $6.9 billion during Q1 2025.